RMCM
EXAS

Reynders McVeigh Capital Management’s Exact Sciences EXAS Stock Holding History

Reynders McVeigh Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,650
Closed -$205K – 231
2021
Q2 		$205K Sell
1,650
-1
-0.1% -$119 0.01% 225
2021
Q1 		$218K Hold
1,651
– – 0.01% 220
2020
Q4 		$219K Buy
+1,651
New +$200K 0.02% 212

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Reynders McVeigh Capital Management's EXAS Position: Q3 2021 in Review

Reynders McVeigh Capital Management sold out of Exact Sciences (EXAS) in Q3 2021, closing a stake of 1,650 shares — an estimated $205K sold.

Reynders McVeigh Capital Management first reported a position in EXAS in Q4 2020 and held it in 3 quarters. The position peaked at $219K in Q4 2020. 602 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

  • Reynders McVeigh Capital Management reported no remaining Exact Sciences position as of Q3 2021 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 1,650 Exact Sciences shares in Q3 2021, an estimated $205K.
  • Reynders McVeigh Capital Management first reported a position in Exact Sciences in Q4 2020 and held it in 3 quarters.
  • Reynders McVeigh Capital Management's Exact Sciences position peaked at $219K in Q4 2020.
  • 602 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on Reynders McVeigh Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.